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SummAry
The need to optimize the use of all the information that modern technological tools have made available to the physician EnT/audiologist has increas-
ingly emerged within the italian scientific community. Towards this purpose, it is necessary to create a registry of the patients using cochlear implants 
(Cis). This registry will include a homogeneous summary of the information deriving from multiple sources related to daily clinical practice, in order 
to assess auditory benefits, safety and reliability in patients with cochlear implants, and organization over the national territory. The primary objec-
tives relative to the above-mentioned analysis are to assess the impact of the use of cochlear implants on patient health, to ensure traceability of the 
devices currently used, monitoring their safety and reliability over time, to guarantee access of the technique in clinical and organizational conditions 
that can allow the best possible benefits. The aspects concerning implementation of the registry were discussed extensively during the first meetings 
of the Working group (Wg). in particular, owing to the complexity and high costs related mainly to the development of the technological aspects 
and the need to involve technological partners external to the Wg, and to respect current privacy laws, the Wg members decided that the project 
should be limited to proposal of a paper registry to be implemented at a later stage, possibly within the framework of successive research projects. 
During meetings, the Wg members discussed various aspects of implementation of the registry, and in particular the scientific features connected to 
objectives, inclusion criteria, and structure of the forms needed for data collection and organizational aspects. A registry is proposed herein.
KEy WorDS: Registry • Cochlear implant • Cochlear implant recipient
riASSunTo
Da qualche tempo in seno alla comunità scientifica italiana sta emergendo sempre più l’esigenza di ottimizzare l’utilizzo di tutte le informa-
zioni che gli strumenti moderni già mettono a disposizione del medico ORL/audiologo. A tale scopo è necessaria la creazione di un registro 
dei pazienti portatori di impianto cocleare, contenente una sintesi ragionata ed omogenea delle informazioni che scaturiscono da più fonti 
nell’ambito della pratica clinica quotidiana, al fine di valutare i benefici uditivi dei pazienti portatori di impianto cocleare, la sicurezza ed 
affidabilità dei dispositivi e l’organizzazione sul territorio nazionale del percorso implantologico del paziente.
Gli obiettivi primari funzionali alla suddetta analisi risultano essere i seguenti: valutare l’impatto dell’utilizzo degli impianti cocleari sulla 
salute dei pazienti, garantire la tracciabilità dei dispositivi impiantabili attualmente in uso, monitorandone la sicurezza ed affidabilità nel 
tempo, garantire l’accesso a questa tecnologia a tutti i cittadini in condizioni cliniche ed organizzative che rendano possibile il raggiungi-
mento dei massimi benefici possibili.
Durante le prime riunioni dei componenti del Gruppo di Lavoro (GdL), sono stati ampiamente discussi gli aspetti relativi alla messa a pun-
to del registro. In particolare vista la complessità e gli alti costi principalmente legati allo sviluppo della parte tecnologica e alla necessità 
di coinvolgere partners tecnologici esterni al GdL e data la necessità di rispettare le normative vigenti in campo di privacy, il GdL decide 
di limitare il presente progetto alla proposta di un registro cartaceo, che potrà essere implementato successivamente, magari nell’ambito 
di successivi progetti di ricerca. Durante le riunioni, i componenti del GdL hanno discusso i vari aspetti riguardanti la messa a punto del 
registro, soprattutto gli aspetti scientifici quali gli obiettivi, i criteri di inclusione, la struttura delle schede di raccolta dati e gli aspetti 
organizzativi. In appendice viene riportata la proposta di registro.
pArolE ChiAvE: Registro • Impianto cocleare • Portatori di impianto cocleare
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Introduction
Rationale for a Registry. The approach and management of 
patients who are suitable candidates for cochlear implanta-
tion varies from one centre to another. The identification 
of candidate subjects, their selection and preparation for 
the intervention, the choice of the device and surgical tech-
niques, as well as the management of post-operative recov-
ery, are critical elements for recovery of auditory function. 
All of these successive phases should be taken into account 
and given their correct predictive value when evaluating the 
outcomes of the implant. in a scenario of this type, it is 
essential to have as much data as possible, collected in a 
standard fashion, applying the same criteria, and with the 
same knowledge and goals.
The need to optimize the use of all the information that 
modern technological tools have made available to the 
otolaryngologist and audiologist has increasingly emerged 
within  the  italian  scientific  community.  unfortunately, 
despite all attempts at standardization, no uniform model 
for outcome assessment in this therapeutic area has been 
reached, representing a limit to the production of high 
quality methodological scientific trials. on the one hand, 
this drawback seems to depend on objective scientific dif-
ficulties, such as the need to represent the results from 
the different points of view of the specialists involved 
(surgeon, otolaryngologist, audiologist, speech therapist, 
patient), and to transpose this information in a quantita-
tive and valid manner. on the other hand, the information 
systems currently available in the different structures are 
often incompatible with one other, making it difficult to 
obtain information that is essential to provide safe, high-
quality care. Essential clinical and technical information, 
often missing in hospital discharge cards, can only be 
obtained by examining clinical records. Furthermore, a 
monitoring system following the implanted patient in the 
course of his life has not been developed. For an integrat-
ed and exhaustive study of the data, the specialists treating 
the candidate for cochlear implantation feel the need for 
an efficient clinical database assessing auditory benefits in 
cochlear implant patients.
health  technology  assessment  is  becoming  one  of  the 
most important institutional tasks falling within the com-
petence of the ministry of health. The need to implement 
a registry for patients using cochlear implants reflects the 
interest of the ministry of health in assessing healthcare 
techniques
 1. The italian financial law for 2007 2 already 
planned to assign part of its funds to activities aimed at 
strengthening the implementation of medical devices. in 
particular, funds have been destined to activities of su-
pervision of the market, control of accidents, technology 
assessment studies, development of registerys for diseases 
requiring the use of medical devices. The interest of the 
health ministry falls within the framework of cochlear 
implantation.
A similar national – or at least regional – initiative is de-
signed to illustrate the state-of-the-art of the three macro 
areas involved in the process, namely clinical, technologi-
cal and clinical governmental.
Towards this end, it is necessary to create a registry of 
patients using cochlear implants. This registry will in-
clude a homogeneous summary of the information de-
riving  from  multiple  sources  related  to  daily  clinical 
practice, in order to assess the auditory benefits, safety 
and reliability of cochlear implants, and organization of 
patient travels. 3 4. The primary objectives to the above-
mentioned analysis are to assess the impact of the use 
of cochlear implants on patient health, to ensure trace-
ability of the devices currently used, monitoring their 
safety and reliability over time and to guarantee access 
of this technique to all citizens in clinical and organisa-
tional conditions, which can allow them to achieve the 
best possible benefits.
Among the benefits resulting from the creation of a reg-
istry, the possibility to obtain outcomes which are sta-
tistically comparable in the different centres is particu-
larly interesting (increasing the robustness of statistical 
analyses performed on a number of cases superior to 
those annually available for each clinic). A registry can 
also help to: i) develop a methodology that is able to 
compare and objectively assess performance of each 
product both from clinical and technological points of 
view; ii) improve clinical practice through standardized 
protocols; iii) improve the quality of practice, thanks to 
an operative monitoring system of the results; iv) as-
sess the appropriateness of treatment, in particular for 
the subject categories for which application of cochlear 
implants must be evaluated carefully; v) increase sci-
entific activities (e.g. clinical studies and publications), 
in particular by developing – if possible – independent 
clinical research based on a number of statistically sig-
nificant cases; and vi) create a national network of cen-
tres involved in cochlear implant procedures, in order 
to exchange experience, clinical advice and opinions.
Methodology: project for a registry 
implementation
The following project for implementation of the reg-
ister was defined during the phase of definition of the 
Aims.
Study methodology
observational,  prospective,  multicentre,  national  or  re-
gional registries.
Recruitment of participating centres
recruitment of structures interested in joining the registry 
(signing a participation form).S. Berrettini et al.
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Inclusion criteria
patients submitted to unilateral or bilateral cochlear im-
plantation, using simultaneous or sequential procedures.
Exclusion criteria
The following patients will be excluded: a) all retrospec-
tive patients, as fragmentation of the information and in-
consistency of the definitions with respect to the termi-
nology requested would make it difficult to complete the 
different registry fields; b) all patients who refuse consent 
to the use of data.
Observation period
A registry of cochlear implant users implies a multiyear 
prospective study of the collected data in order to obtain 
preliminary,  clinically-reliable  results  and  implant  reli-
ability outcomes. Therefore, it is necessary to have a suf-
ficiently large number of cases. only long-term results are 
possible, because failure of devices and clinical benefits 
can only be assessed over the long-term. These aspects 
often come into conflict with the needs of institutions and 
projects seeking short-term results.
Data analysis
in accordance with statistical analysis planning and tech-
nological platform features, the system will include differ-
ent types of reports, as well as analytical and synthetic data 
processing related to scientific and organizational aspects.
The information obtained from this collection of data will 
concern: a) clinical epidemiology of implanted deaf pa-
tients; b) epidemiology of treatment; c) epidemiology of 
therapeutic-diagnostic protocols; d) compliance of Cen-
tres to guidelines; e) postmarketing surveillance (study 
of implant survival), and analysis of risk factors that may 
influence outcome (e.g. different lifestyles of the patient); 
f) direct analysis of sanitary and social costs by assess-
ment  of  economic  implications  determined  by  the  use 
of cochlear implants and recovery of auditory abilities; 
g) new routes/applications; h) best practices: identifica-
tion and dissemination.
Logical structure of the database
in order to obtain adhesion to the registry by as many cen-
tres as possible, it is necessary to identify a minimum set 
of data that is both comprehensive and functional to the 
aims proposed.
identification of the two data levels can be divided into: 
a) obligatory data, functional to the objectives of the reg-
istry, accessible to as many national centres as possible; 
b) large amounts of non-obligatory data, alongside a mini-
mum group of obligatory data, but only accessible to the 
few reference centres able to support the collection.
The data collected can be subdivided into three principal 
subsets.
The first subset of data allows identification of the patient 
and his/her clinical course within the hospital structure 
(identifying organization indicators, e.g. separation be-
tween  place  of  first  intervention  and  follow-up  and/or 
post-intervention; waiting times between diagnosis and 
intervention, intervention and activation, etc.).
The second subset of data includes technical information 
relative to the devices used (both implantable and exter-
nal), to allow traceability of the implant during the pa-
tient’s life when associated with previous data (analysis 
of reliability/survival curve of the implant).
The third subset of data concerns clinical data, or infor-
mation related to anamnesis, surgical intervention, activa-
tion and follow-up. These elements are necessary to trace 
the clinical profile of the patient and to check the impact 
of cochlear implant usage on patient health, i.e. auditory 
benefit and improvement of quality of life.
e-CRF (electronic-Case Report Form) design and data 
management
Technical development of the project in terms of prepara-
tion of the registry will be assigned to one or more tech-
nological partners (clinical research organization (Cro), 
university, research institute or other), and will concern 
both the practical aspects (from design and implementa-
tion of the e-CrF, with on-line control, generation of on-
going queries, to creation of the database, including data-
clearing and production of tables and statistical reports 
in agreement with a pre-established study plan), and the 
maintenance  aspects  (hosting  server,  constant  back-up, 
connections, usage licenses).
The e-CrF will include both obligatory and optional fields 
that will be differentiated to obtain two possible registry 
levels. The system will periodically check for congruence 
and completion, and send warning messages aimed at cor-
recting any input mistakes made by users. All variables 
introduced in the registry will be codified by standard 
definitions and appropriate terminology to ensure a sys-
tematic approach to collection and inclusion of the data).
The server hosting the data will be protected, validated 
for the purpose and submitted to rigid back-up and anti-
intrusion protocols.
in the case of data collected on paper forms, further re-
sources for data inclusion will be necessary to perform the 
above-mentioned activities.
Data flow recording
The mode of data inclusion suggested is through a web-
interface, owing to the practical management that the in-
formation system offers with respect to traditional record-
ing on paper forms. The data will be collected in a resident 
database stored on a centralized server owned by the reg-
istry group. The intervention of a technological provider 
will be necessary for implementation of the data collec-
tion cards. Transmission of the data, from local clinical to 
central registry sites, will essentially need to respond to A registry for data on cochlear implant recipients
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the following principle: the data must be transmitted safe-
ly. This includes cryptography of the information as well 
as possibility of access after the authentication procedure. 
Furthermore, it will be possible for the person responsible 
for each centre, using a password, to access, consult and 
update at any time the data of his/her own centre. Con-
sultation of the “national” data of the registry will also be 
allowed, with the following rules safeguarding privacy: 
this collection of data will be completely anonymous, pre-
venting identification of patient and centre.
Privacy
All possible solutions should be taken to protect patients’ 
right  to  privacy  and  data  security  in  compliance  with 
“code 196 concerning personal data protection”, and the 
more recent guidelines of July 2008 “for treatment of per-
sonal data in the field of experimental clinical experimen-
tation” 5. The patient should consent to treatment of his/
her data, signing an informed consent form.
Conclusions and implementation of the 
project
The aspects concerning registry implementation were 
discussed extensively during the first meetings of the 
Working  group  (Wg)  members. in  particular,  owing 
to the complexity and high costs related mainly to the 
development of the technological part and the need to 
involve technological partners external to the Wg and 
to respect current privacy laws, the Wg members de-
cided that the project should be limited to the proposal 
of a paper registry to be implemented at a later stage, 
possibly within the framework of successive financed 
research projects.
The Wg members discussed various aspects of imple-
mentation of the registry, and in particular the scientific 
features related to objectives, inclusion criteria and struc-
ture of the forms related to data collection and organisa-
tional aspects.
The registry proposal is reported in Appendix 1.
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Part 1 – Personal Details
pArTiCipATion ConSEnT/DATA TrEATmEnT Dl 196/03  ❏ yES (pATiEnT)
        ❏ yES (pArEnT/TuTor)
1* Progressive card n° |__|__|__|__|__|  2* Clinical card n° |__|__|__|__|__|__|__|__|__|__|__|__|__|__|
3* Hospital______________________________    4* Ward/Division_______________________________  
5* Surname_____________________________    6* Name______________________________________  
7* Sex  |__| m     |__| F       8* Date of birth ___ / ___ / ______
                                                                                      day  month    year
9* Place of birth__________________________   10 Province of birth             |__|__|
     or Foreign Country
11* Municipality of residence_______________   12 Province of residence |__|__|
  or Foreign Country 
13 Fiscal Code |__|__|__|__|__|__|__|__|__|__|__|__|__|__|__|__|  14 Nationality_______________________  
15 Telephone number______________________   Mobile phone___________________________________  
16 E-mail address_________________________________________________________________________  
17 Civil status____________________________   18 Educational qualification_______________________  
19 Current occupation______________________________________________________________________  
20* Admission date  ___ / ___ / _______  21* Intervention date  ___ / ___ / _______
                             day  month    year                               day   month     year
22* Discharge date  ___ / ___ / _______or   22a Transfer date  ___ / ___ / _______
                             day  month    year                               day    month    year
23* Patient sent by:
❏ Doctor or Family Paediatrician
❏ Password, Internet
❏ Neonatology screening
❏ Specialist ORL-Audiologist
❏ Other (specify)
Appendix I 
Registry proposal for collection of patient data
Cochlear Implant Registry
Retrieval Information CardA registry for data on cochlear implant recipients
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Part 2 – Clinical Data
24* Deafness onset time:
❏ prelingual (< 1 yr)  ❏ perilingual (1-3 yrs)  ❏ postlingual (> 3 yrs)
❏ late postlingual (7-18 yrs)  ❏ Adult age (≥ 18 yrs)
❏ Congenital  ❏ Acquired  ❏ undefinable
25* Age of hearing loss first diagnosis:_________________________________________________________  
26* Hypoacusia trend  ❏ progressive  ❏ Stable
27a* Aetiology of paediatric hypoacusia
❏ genetic:  ❏ isolated  ❏ Syndromic (specify___________________________________________  )
 ( ❏ recessive    ❏ dominant  ❏ mitochondrial       ❏ other (specify _______________________  )
❏ inner ear malformations (specify ___________________________________________________________   )
❏ Achieved cause
  ❏ prenatal-infective  ❏ Cmv           ❏ Toxoplasma
    ❏ other (specify _______________________________________________  )
  ❏ perinatal    ❏ Tin
    ❏ other (specify _______________________________________________  )
  ❏ postnatal    ❏ meningitis
    ❏ other (specify _______________________________________________  )
❏ unknown
27b* Aetiology of adult hearing loss
❏ genetic:  ❏ isolated  ❏ Syndromic (specify___________________________________________  )
 ( ❏ recessive    ❏ dominant  ❏ mitochondrial       ❏ other (specify ________________________ )
❏ inner ear malformations (specify____________________________________________________________  )
❏ otosclerosis
❏ meningitis
❏ other (specify __________________________________________________________________________  )
28* Admission-associated pathologies (more than one answer is possible)
❏ none
❏ hypertension
❏ diabetes
❏ malformation syndromes (❏ middle ear    ❏ external ear   ❏ other )
❏ nervous system diseases
❏ cerebrovascular diseases
❏ respiratory diseases
❏ neuropsychiatric paediatric diseases_____________  ❏ mental retardation
❏ acute visual deficit_____________________________  ❏ cerebral palsy
❏ other (specify_____________________)     ❏ pervasive development disorders
        ❏ attention deficit with/without hyperactivity
        ❏ other  
29* Use of hearing aids/devices/Cochlear Implant
❏ no
❏ yES (hearing aids) (age of first fitting________   ❏ righT  ❏ lEFT    ❏ Bil – type (specify____ )
❏ yES: Ci user: ❏ righT (Brand-model ______ ) – Age of Ci positioning:____________________________  
  ❏ lEFT (Brand-model ________ ) – Age of Ci positioning: ___________________________ 
❏ yES (vibro-tactile stimulation)
❏ observations-Annotations____________________________________________________________________  S. Berrettini et al.
334
30* In case of children and adults was rehabilitation treatment performed?
❏ yES (number of weekly sessions for months________________   ❏ oralist  ❏ Sign language
❏ no
31* Duration of hearing deprivation (months/years)  
____________________________________________________
32* Otoscopy
Right  ❏ negative - ❏ positive (specify_______________________________________________________   )
Left  ❏ negative - ❏ positive (specify_______________________________________________________   )
33 Tonal Audiometry without prosthesis (*adults, **children)
dB  250 Hz  500 Hz 1000 Hz 2000 Hz 4000 Hz 8000 Hz
*R
*L
**F.F.
34 Tonal Audiometry with hearing aids (*adults, **children)
dB  250 Hz  500 Hz 1000 Hz 2000 Hz 4000 Hz 8000 Hz
R Pr. 
L Pr.
*, **F.F.
35* Vocal Audiometry (*adults, **children)
% maximum verbal discrimination reached %__________________    dB _______________________ 
36* Tympanometry
  Right  ❏ normal - ❏ pathological (specify______________________________________________   )
  Left  ❏ normal - ❏ pathological (specify______________________________________________   )
37* Stapedial Reflexes
  Right  ❏ present - ❏ absent
  Left  ❏ present - ❏ absent
38* A.B.R. threshold V wave:  ❏ absent
    ❏ right threshold: (specify_______________________________________   )
    ❏ left threshold: (specify________________________________________   )
39 Test of speech perception abilities (* adults, ** children)
** perceptive Category of moog & geers______________________________________________________  
** Questionnaire score at mAiS _____________________________________________________________ 
* % of recognition of bisyllabic words in open-set in auditory mode (also obligatory in children with sufficient lexicon 
for test performance) ______________________________________________________________________ 
40 Assessment of language development (obligatory only for patients in paediatric age)
** Questionnaire score muSS ________________________________________________________________ 
phonetic inventory ________________________________________________________________________ 
lexical level (specify score and test used) comprehension______________    production_________________  
morphosyntactic level (specify score and test used) comprehension______    production ________________ A registry for data on cochlear implant recipients
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41* Diagnostic Imaging
CT of Petrous bones:
❏ yES (❏ normal  ❏ alterations_____________________________________  )  ❏ no
MR of the inner ear:
❏ yES (❏ normal  ❏ alterations _____________________________________ )  ❏ no
MR of the acoustic nerve and internal auditory canal:
❏ yES (❏ normal  ❏ alterations_____________________________________  )  ❏ no
MR of the brain:
❏ yES (❏ normal  ❏ alterations_____________________________________  )  ❏ no
Part 3 – Surgical Data
42* Surgeon     43* Date of surgery  ___ / ___ / _______
                                               day  month     year
44* Side
❏ righT
❏ lEFT
❏ BilATErAl (❏ simultaneous - ❏ sequential: time between 2 Ci:__________________________________  
45* Duration of intervention  1° int. |__|__| |__|__|  2° int. |__|__| |__|__|
       (cutis-cutis)                                           hr      min                 hr      min
46* CI brand
Right
❏ ABC – Advanced Bionics Corporation (model ________________________________________________  )
❏ Cochlear (model ________________________________________________________________________  )
❏ med-el (model _________________________________________________________________________  )
❏ neurelec (model ________________________________________________________________________  )
Left
❏ ABC – Advanced Bionics Corporation (model ________________________________________________  )
❏ Cochlear (model ________________________________________________________________________  )
❏ med-el (model_________________________________________________________________________   )
❏ neurelec (model________________________________________________________________________   )
47* N° of series implant
Right ________________________________________   Left____________________________________  
48* Type of intervention
❏ implant
❏ revision
❏ Explantation (❏ righT (Brand-model_____________   )  ❏ lEFT (Brand-model ______________  )
❏ replanting (❏ righT (Brand-model______________   )  ❏ lEFT (Brand-model______________   )
❏ 1. Explantation - 2. replanting (simultaneous):
  1. (❏ right (Brand-model __________________  )  ❏ left (Brand-model _______________  )
  2. (❏ right (Brand-model __________________  )  ❏ left (Brand-model _______________  )
ministry documentation sent on _____________________ S. Berrettini et al.
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49* Reason for Explantation
Medical:
❏ extrusion – infection
❏ extrusion – necrosis edge
❏ other (specify___________________________________________________________________________  )
Techniques:
❏ rupture
❏ Soft failure (6,7)
❏ technology advancements
❏ no use of implant (specify_________________________________________________________________   )
❏ other (specify __________________________________________________________________________  )
50* Antibiotic prophylaxis
❏ yES
❏ no
Surgical Technique
51* Cutaneous incision  ❏ Enlarged retroauricular (inverted l) ❏ minimum retroauricular
❏ other (specify __________________________________________________________________________  )
52* Particular cases:
❏ Chronic otitis media
❏ inner ear malformation (specify ____________________________________________________________  )
❏ Cochlear ossification (specify______________________________________________________________   )
❏ other (specify __________________________________________________________________________  )
53* Electrode insertion ❏ round window  ❏ Anterior Cochleostomy  ❏ perifenestral Cochleostomy
❏ other (specify __________________________________________________________________________  )
❏ perimodiolar insertion technique
❏ non-perimodiolar insertion technique
54* Cochleostomy Size ____________________________________________________________________ 
55* Cochleostomy closure__________________________________________________________________  
56* N° of electrodes inserted  ❏ all  ❏ number (specify_______________________________________  )
57* Receptor-stimulator fixing  ❏ Fissure with non-reabsorbable suture passed through osseous tunnel
    ❏ Seat and anterior osseous tunnel
    ❏ no fissure
    ❏ other (specify _______________________________________________  )
58* Intraoperational measures
Neural telemetry
❏ not performed
❏ performed (❏ normal# ❏ pathological)
Telemetry Impedance
❏ not performed
❏ performed (❏ normal# ❏ pathological)
(# normal if at least 3 electrodes are present for which action potentials are identified)A registry for data on cochlear implant recipients
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Complications
59* Intraoperative (multiple answers possible)
❏ none       ❏ liquorrea     ❏ gusher       ❏ haemorrhage  ❏ anaesthesia
❏ Difficult insertion of electrode    ❏ other (specify_________________________________________   )
60* Postoperative (multiple answers possible; specify onset time after intervention and duration)
❏ none
❏ haemorrhage ______________________________________________  Time _________________________ 
❏ haematoma ________________________________________________ Time _________________________ 
❏ liquorrea __________________________________________________ Time _________________________  
❏ infection of the flap _________________________________________  Time _________________________ 
❏ necrosis of the temporal flap___________________________________ Time _________________________
❏ meningitis___________________________________________________Time ______________________  
❏ electric stimulation of facial nerve________________________________Time ______________________
❏ post-traumatic facial paralysis___________________________________ Time ______________________  
❏ extrusion-infection____________________________________________Time ______________________ 
❏ vertigo _____________________________________________________Time ______________________
❏ disgeusia___________________________________________________ Time ______________________  
❏ xerostomy__________________________________________________ Time ______________________  
❏ tinnitus_____________________________________________________ Time ______________________ 
❏ electrode extrusion (specify number) _____________________________ Time _______________________ 
❏ traumatic failure device________________________________________ Time _______________________
❏ spontaneous failure device______________________________________Time _______________________
❏ rupture - soft failure of inside part of the implant____________________ Time _______________________ 
❏ other (specify ___________________________)____________________ Time________________________  
Part 4 – Activation and Fitting Data
61* Post-implantation X ray
❏ correct position          ❏ lateral wall   ❏ medial wall
❏ erroneous position (specify________________________________________________________________   )
62* Activation Data ______________________________________________________________________ 
63* Brand/ Processor Model
Right
❏ ABC – Advanced Bionics Corporation (model_________________________________________________  )
❏ Cochlear (model ________________________________________________________________________  )
❏ med-el (model __________________________________________________________________________ )
❏ neurelec (model ________________________________________________________________________  )
Left
❏ ABC – Advanced Bionics Corporation (model_________________________________________________  )
❏ Cochlear (model_________________________________________________________________________  )
❏ med-el (model__________________________________________________________________________  )
❏ neurelec (model_________________________________________________________________________  )
64* Series processor n°
Right__________________________________________   Left____________________________________  S. Berrettini et al.
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65* Coding strategy
SPeak (❏ righT - ❏ lEFT)  CIS (❏ righT - ❏ lEFT)  ACE (❏ righT - ❏ lEFT) 
CIS-RE (❏ righT - ❏ lEFT)  ACE-RE (❏ righT - ❏ lEFT)  FFT (❏ righT - ❏ lEFT) 
SAS (❏ righT - ❏ lEFT)  Other (❏ righT - ❏ lEFT) specify ______________________________ 
66* Use of acoustic hearing aid – Bimodal stimulation  ❏ yES  ❏ no
if yES, specify type and brand of prosthesis ____________________________________________________ 
if no, specify reason ______________________________________________________________________   
67* Neural Response  ❏ yES    ❏ no
68* Electrode impedance
❏ Active
❏ presence of non-functioning electrodes (specify _______________________________________________  )
69 Audiometric Test in free field with CI
dB HL  250 Hz  500 Hz 1000 Hz 2000 Hz 4000 Hz
R CI
L CI
 R+L CI
    
70* Pure tone audiometry of the implanted ear (obligatory only for collaborating adults and children aged > 6 yrs)
dB  250 Hz  500 Hz 1000 Hz 2000 Hz 4000 Hz
 R
 L
71 Other (specify ________________________________________________________________________)
1st month post–activation
72* Use of acoustic hearing aid– Bimodal stimulation  ❏ yES    ❏ no
if yES, specify type and prosthesis brand _______________________________________________________ 
if no, specify reason _______________________________________________________________________ 
73* Neural Response  ❏ yES    ❏ no
74* Coding strategies
SPeak (❏ righT - ❏ lEFT)  CIS (❏ righT - ❏ lEFT)  ACE (❏ righT - ❏ lEFT) 
CIS-RE (❏ righT - ❏ lEFT)  ACE-RE (❏ righT - ❏ lEFT)  FFT (❏ righT - ❏ lEFT) 
SAS (❏ righT - ❏ lEFT)
Other (❏ righT - ❏ lEFT) specify___________________________________________________________  
75* Electrode impedence
❏ ok
❏ presence of non-functioning electrodes (specify________________________________________________  )A registry for data on cochlear implant recipients
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76* Audiometric test in free field with CI
dB HL  250 Hz  500 Hz 1000 Hz 2000 Hz 4000 Hz
RIGHT CI
LEFT CI 
 (R+L) CI 
   
77* Pure tone audiometry of implanted ear (obligatory only for collaborating adults and children aged > 6 yrs)
dB  250 Hz  500 Hz 1000 Hz 2000 Hz 4000 Hz
R
L
78* Test of speech perception abilities (*adults, **children)
** perceptive categories of moog & geers ______________________________________________________ 
** Questionnaire score at mAiS_______________________________________________________________  
* % of recognition of disyllabic words in open-set in auditory mode 
(obligatory also in children with sufficient lexicon for test performance)_______________________________  
6th month post–activation
79* Use of hearing aid– Bimodal Stimulation  ❏ yES     ❏ no
if yES, specify type and brand of prosthesis   _____________________________________________________ 
if no, specify why _________________________________________________________________________ 
80* Neural Response   ❏ yES    ❏ no
81* Coding strategies
SPeak (❏ r - ❏ l)  CIS (❏ r - ❏ l) ACE (❏ r - ❏l)  CIS-RE (❏ r - ❏ l) 
ACE-RE (❏ r - ❏ l)  FFT (❏ r - ❏ l)  SAS (❏ r - ❏ l)
Other (❏ r - ❏ l) specify___________________________________________________________________  
82* Electrode Impedance
❏ ok
❏ presence of non-working electrodes (specify___________________________________________________  )
83* Free field audiometry with CI
dB HL  250 Hz  500 Hz 1000 Hz 2000 Hz 4000 Hz
R CI
L CI
 (R+L) CI
    
84* Pure tone audiometry of the implanted ear (only obligatory for collaborating adults and children > 6 yrs)
dB  250 Hz  500 Hz 1000 Hz 2000 Hz 4000 Hz
R
LS. Berrettini et al.
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85* Test of speech perception abilities (*adults, **children)
** perceptive category of moog & geers_______________________________________________________  
** Questionnaire score. mAiS________________________________________________________________  
* % of recognition of disyllabic words in open-set in hearing modality 
(obligatory also for children with sufficient lexicon for performance of the test)_________________________  
86 Other (specify__________________________________________________________________________  )
87 Assessment of language development (obligatory only for paediatric patients)
**Questionnaire score at muSS_______________________________________________________________  
phonetic inventory _________________________________________________________________________ 
lexical level (specify score and test used) comprehension_______________    production_________________  
morphosyntactic level (specify score and test used) comprehension_______   production_________________
Check-up 1 year (as control at 6 months post-activation)
Annual check-up (as control at 6 months post-activation)
Explicatory notes for compilation of retrieval information card (ric)
*: the asterisk indicates obligatory fields to be compiled (others are optional)
**: obligatory fields only for children
For each question, unless specified, give only one answer
1:  card number – assign a progressive number to the cards;
2:  progressive admission number – the hospital assigns a progressive number to each card;
  it must be univocal in the year and allow rapid retrieval of the card;
4:  ward/division – it refers to the ward/division of the intervention;
17-18:  civil status end qualification – the information must come from the patient and refer to the time at which the 
card is compiled;
19:  current occupation – the information is referred to patient’s occupation (even if s(he) is temporarily unem-
ployed due to illness);
33-34:  F.F. = free field.